S. Retamozo

发表

C. S. Cheong, W. Loh, T. K. Loh, 2021, Surgery of the Salivary Glands.

Infection is the major trigger of hemophagocytic syndrome in adult patients treated with biological therapies.

A. López-Guillermo, M. Khamashta, X. Bosch, 2016, Seminars in arthritis and rheumatism.

Validation of the classification criteria for cryoglobulinaemic vasculitis.

A. Gabrielli, S. Bombardieri, D. Sansonno, 2014, Rheumatology.

Influence of the age at diagnosis in the disease expression of primary Sjögren syndrome. Analysis of 12,753 patients from the Sjögren Big Data Consortium.

A. Vissink, D. Isenberg, J. Sánchez-Guerrero, 2021, Clinical and experimental rheumatology.

An update of targeted therapeutic options for primary Sjögren syndrome: current status and future development

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2021, Expert opinion on pharmacotherapy.

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project).

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2018, Clinical and experimental rheumatology.

Prognostic markers of lymphoma development in primary Sjögren syndrome

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2019, Lupus.

Cytokines as therapeutic targets in primary Sjögren syndrome

M. Ramos-Casals, S. Retamozo, A. Flores-Chávez, 2017, Pharmacology & therapeutics.

Haemophagocytic syndrome and COVID-19

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2021, Clinical Rheumatology.

Interstitial lung disease induced or exacerbated by TNF-targeted therapies: analysis of 122 cases.

X. Bosch, M. Ramos-Casals, S. Retamozo, 2011, Seminars in arthritis and rheumatism.

OP0213 The Degree of Activity Measured with the EULAR-SS Disease Activity Index (ESSDAI) Strongly Correlated with Death in Patients with Primary Sjogren Syndrome (GEAS-SS REGISTRY)

B. Kostov, M. Ramos-Casals, S. Retamozo, 2014 .

Immunological Tests in Primary Sjögren Syndrome

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2011 .

First Latin American clinical practice guidelines for the treatment of systemic lupus erythematosus: Latin American Group for the Study of Lupus (GLADEL, Grupo Latino Americano de Estudio del Lupus)–Pan-American League of Associations of Rheumatology (PANLAR)

E. Soriano, G. Alarcón, C. Pineda, 2018, Annals of the rheumatic diseases.

Epidemiological profile and north-south gradient driving baseline systemic involvement of primary Sjögren's syndrome.

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2019, Rheumatology.

Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2019, Expert review of clinical immunology.

Monoclonal gammopathy related to Sjögren syndrome: a key marker of disease prognosis and outcomes.

X. Bosch, M. Ramos-Casals, S. Retamozo, 2012, Journal of autoimmunity.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Systemic Lupus Erythematosus: Indirect B-Cell Blocking

M. Khamashta, X. Bosch, M. Ramos-Casals, 2014 .

Autoimmune congenital heart block and primary Sjögren's syndrome: characterisation and outcomes of 49 cases.

A. Vissink, X. Mariette, B. Kostov, 2020, Clinical and experimental rheumatology.

Therapeutic Recommendations for the Management of Older Adult Patients with Sjögren’s Syndrome

A. Vissink, X. Mariette, Y. Shoenfeld, 2021, Drugs & Aging.

Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.

J. Sánchez-Guerrero, X. Mariette, S. Bombardieri, 2019, Clinical and experimental rheumatology.

Sarcoidosis: an update on current pharmacotherapy options and future directions

R. Baughman, M. Ramos-Casals, S. Retamozo, 2016, Expert opinion on pharmacotherapy.

Hepatitis B Virus (HBV) Reactivation in Patients Receiving Tumor Necrosis Factor (TNF)-Targeted Therapy: Analysis of 257 Cases

L. López-Rosés, X. Forns, J. Sánchez-Tapias, 2011, Medicine.

Erratum to: Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2016, Drugs.

Treating the Underlying Pathophysiology of Primary Sjögren Syndrome: Recent Advances and Future Prospects

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2016, Drugs.

Etiopathogenic Role of Surfactant Protein D in the Clinical and Immunological Expression of Primary Sjögren Syndrome

B. Kostov, A. Sisó-Almirall, X. Bosch, 2015, The Journal of Rheumatology.

Life-Threatening Cryoglobulinemia

X. Bosch, M. Ramos-Casals, S. Retamozo, 2011 .

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

B. Kostov, M. Ramos-Casals, S. Retamozo, 2014, Annals of the rheumatic diseases.

Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren's syndrome.

X. Bosch, M. Ramos-Casals, S. Retamozo, 2012, Clinical and experimental rheumatology.

Evidence-based recommendations on the management of extrahepatic manifestations of chronic hepatitis C virus infection.

A. Mangia, Z. Younossi, A. Tzioufas, 2017, Journal of hepatology.

pulmo-Review Practical diagnostic tips for the Sjögren Clinic: pearls, myths and mistakes GEAS-SEMI

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2022 .

Childhood-onset of primary Sjögren's syndrome: phenotypic characterization at diagnosis of 158 children.

A. Vissink, D. Isenberg, X. Mariette, 2021, Rheumatology.

Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.

A. Vissink, D. Isenberg, J. Gottenberg, 2020, Clinical and experimental rheumatology.

Childhood-onset of primary Sjogren syndromePhenotypic characterization at diagnosis of 158 children

A. Vissink, D. Isenberg, S. Bombardieri, 2020, medRxiv.

Shrinking lung syndrome and pleural effusion as an initial manifestation of primary Sjögren’s syndrome

S. Retamozo, F. Caeiro, D. Baenas, 2020 .

Efficacy and safety of topical and systemic medications: a systematic literature review informing the EULAR recommendations for the management of Sjögren’s syndrome

X. Mariette, J. Gottenberg, T. Dörner, 2019, RMD Open.

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry).

B. Kostov, M. Ramos-Casals, S. Retamozo, 2018, Clinical and experimental rheumatology.

Phenotyping Sjögren's syndrome: towards a personalised management of the disease.

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2018, Clinical and experimental rheumatology.

How hepatitis C virus modifies the immunological profile of Sjögren syndrome: analysis of 783 patients

X. Forns, J. Sánchez-Tapias, S. Kaveri, 2015, Arthritis Research & Therapy.

How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients.

B. Kostov, M. Ramos-Casals, S. Retamozo, 2015, International immunopharmacology.

Systemic involvement in primary Sjogren's syndrome evaluated by the EULAR-SS disease activity index: analysis of 921 Spanish patients (GEAS-SS Registry).

B. Kostov, M. Ramos-Casals, S. Retamozo, 2014, Rheumatology.

Annular erythema in primary Sjögren’s syndrome: description of 43 non-Asian cases

B. Kostov, X. Bosch, M. Ramos-Casals, 2014, Lupus.

Classification and characterisation of peripheral neuropathies in 102 patients with primary Sjögren's syndrome.

J. Valls-Solé, X. Bosch, M. Ramos-Casals, 2013, Clinical and experimental rheumatology.

THU0291 Gender influence on clinical, biological and immunological aspects of systemic lupus erythematosus

S. Retamozo, M. Lamloum, V. Saurit, 2017 .

[Nephrocalcinosis and proximal tubulopathy in Sjögren's Syndrome.]

S. Retamozo, V. Saurit, F. Caeiro, 2018, Revista de la Facultad de Ciencias Medicas.

Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2015 .

Introducing treat-to-target strategies of autoimmune extrahepatic manifestations of chronic hepatitis C virus infection

L. Quartuccio, S. De Vita, M. Ramos-Casals, 2017, Expert review of clinical pharmacology.

Life-Threatening Cryoglobulinemic Patients With Hepatitis C

J. Yagüe, X. Forns, X. Bosch, 2013, Medicine.

Development of lymphoma in patients with primary Sjögren syndromes

S. Retamozo, G. Salvatierra, L. Ratti, 2019 .

Systemic Therapy of Sjögren Syndrome

M. Ramos-Casals, S. Retamozo, P. Brito-Zerón, 2016 .

Sjögren syndrome.

M. Ramos-Casals, Pilar Brito-Zerón, S. Retamozo, 2022, Medicina clínica (Ed. impresa).

SP0190 2019 EULAR RECOMMENDATIONS FOR THE MANAGEMENT OF SJöGREN”S SYNDROME WITH TOPICAL AND SYSTEMIC THERAPIES

X. Mariette, Y. Shoenfeld, S. Bombardieri, 2019, Speaker Abstracts.

Digestive Involvement in Primary Sjögren's Syndrome

B. Kostov, M. Ramos-Casals, S. Retamozo, 2017 .

Autoimmune diseases induced by biological agents. A review of 12,731 cases (BIOGEAS Registry)

B. Kostov, M. Ramos-Casals, S. Retamozo, 2017, Expert opinion on drug safety.

SARS-CoV-2 infection in patients with primary Sjögren syndrome: characterization and outcomes of 51 patients

A. Vissink, F. Giardina, D. Isenberg, 2020, Rheumatology.

Influence of geolocation and ethnicity on the phenotypic expression of primary Sjögren's syndrome at diagnosis in 8310 patients: a cross-sectional study from the Big Data Sjögren Project Consortium

D. Isenberg, J. Sánchez-Guerrero, X. Mariette, 2016, Annals of the rheumatic diseases.

EULAR recommendations for the management of Sjögren’s syndrome with topical and systemic therapies

X. Mariette, Y. Shoenfeld, S. Bombardieri, 2019, Annals of the rheumatic diseases.

Diagnosing unexplained fever: can quick diagnosis units replace inpatient hospitalization?

X. Bosch, S. Retamozo, A. López-Soto, 2014, European Journal of Clinical Investigation.

Characterization and risk estimate of cancer in patients with primary Sjögren syndrome

A. López-Guillermo, B. Kostov, A. Sisó-Almirall, 2017, Journal of Hematology & Oncology.

Cryoglobulinemia: Study of Etiologic Factors and Clinical and Immunologic Features in 443 Patients from a Single Center

J. Yagüe, M. García-Carrasco, R. Cervera, 2001, Medicine.

Diagnosis of Liver Involvement in Primary Sjögren Syndrome

B. Kostov, M. Ramos-Casals, S. Retamozo, 2013, Journal of clinical and translational hepatology.

THU0628 IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES. BIG DATA ANALYSIS OF 13,051 CASES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

AB0542 Blocking the Human B Lymphocyte Stimulator Molecule (BLYS) Using A Monoclonal Antibody (Belimumab) in Systemic Lupus Erythematosus: First Results in Real-Life Spanish Patients with Refractory Disease (Biogeas-Semi Registry)

G. Ruiz-Irastorza, M. Ramos-Casals, S. Retamozo, 2014 .

Cryoglobulinemic disease.

J. Stone, X. Bosch, M. Ramos-Casals, 2013, Oncology.

SAT0206 Minimally-Invasive Technique for the Biopsy of Minor Salivary Glands: Searching for Systemic Infiltrative Diseases in Patients Presenting with SICCA Symptoms

B. Kostov, M. Ramos-Casals, S. Retamozo, 2014 .

White matter abnormalities in primary Sjögren syndrome.

Y. Blanco, A. Saiz, X. Bosch, 2012, QJM : monthly journal of the Association of Physicians.

General characteristics of an early arthritis cohort in Argentina.

M. Benegas, S. Retamozo, A. Berman, 2011, Rheumatology.

SARS-CoV-2 infection in patients with systemic autoimmune diseases.

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2021, Clinical and experimental rheumatology.

Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection

V. Devauchelle-Pensec, A. Sisó-Almirall, B. Armağan, 2021, Clinical and Experimental Rheumatology.

Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.

B. Kostov, A. Sisó-Almirall, L. Quartuccio, 2016, Rheumatology.

Shrinking lung syndrome and pleural effusion as an initial manifestation of primary Sjögren's syndrome.

S. Retamozo, F. Caeiro, D. Baenas, 2018, Reumatologia clinica.

Factors influencing dry mouth in patients with primary Sjögren syndrome: usefulness of the ESSPRI index.

B. Kostov, A. Sisó-Almirall, M. Ramos-Casals, 2014, Oral health and dental management.

THU0649 PHENOTYPIC CLUSTERS OF RHEUMATIC/SYSTEMIC IMMUNE-RELATED ADVERSE EVENTS INDUCED BY CANCER IMMUNOTHERAPIES (IMMUNOCANCER INTERNATIONAL REGISTRY)

M. Suarez‐Almazor, X. Mariette, J. Gottenberg, 2019, Poster Presentations.

Effects of cigarette smoking on early arthritis: a cross-sectional study—data from the Argentine Consortium for Early Arthritis (CONAART)

E. Soriano, M. Benegas, S. Retamozo, 2015, Rheumatology International.

THU0399 Systemic Amyloidosis as A Multi-Organ, Life-Threatening Disease: Predictive Baseline Factors Associated to Mortality in 570 Patients (Ramyd-Geas-Semi Registry)

D. Real de Asúa, X. Bosch, M. Ramos-Casals, 2014 .

SAT0683 A north-south worldwide gradient in systemic activity of primary sjÖgren syndrome: increased severe disease in patients from southern countries

D. Isenberg, J. Gottenberg, V. Devauchelle-Pensec, 2018, Saturday, 16 JUNE 2018.

Characterization and outcomes of 414 patients with primary SS who developed hematological malignancies.

A. Vissink, D. Isenberg, X. Mariette, 2022, Rheumatology.

Mortality risk factors in primary Sjögren syndrome: a real-world, retrospective, cohort study

A. Vissink, X. Mariette, S. Bombardieri, 2023, eClinicalMedicine.

SAT0596 Thoracic involvement at diagnosis drives a differentiated clinical presentation of sarcoidosis: analysis of 1245 patients (SARCOGEAS-SEMI)

M. Penadés, B. Kostov, X. Bosch, 2018 .

THU0018 Angiotensinogen as a marker of injury in lupus nephritis

S. Retamozo, V. Saurit, A. Alvarellos, 2017 .

Practical diagnostic tips for the Sjögren Clinic: pearls, myths and mistakes.

A. Sisó-Almirall, M. Ramos-Casals, S. Retamozo, 2022, Clinical and experimental rheumatology.

Sjögren syndrome

M. Ramos-Casals, S. Retamozo, P. Brito‐Zerón, 2023, Medicina Clínica (English Edition).

Cryoglobulinemia.

L. Quartuccio, S. Retamozo, M. Ramos-Casals, 2022, Medicina clinica.

Crioglobulinemia

L. Quartuccio, S. Retamozo, M. Ramos-Casals, 2022, Medicina Clínica.

[Treatment of cryoglobulinemic vasculitis associated with hepatitis C virus infection].

M. Ramos-Casals, Pilar Brito-Zerón, S. Retamozo, 2015, Medicina clinica.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Influence of exposure to climate-related hazards in the phenotypic expression of primary Sjögren's syndrome.

B. Armağan, V. Fernandes Moça Trevisani, G. Nordmark, 2023, Clinical and experimental rheumatology.

Extensive Calcinosis in Adult Dermatomyositis

S. Retamozo, V. Saurit, A. Alvarellos, 2019, Reumatología Clínica (English Edition).

Systemic activity and mortality in primary Sjögren syndrome: predicting survival using the EULAR-SS Disease Activity Index (ESSDAI) in 1045 patients

B. Kostov, M. Ramos-Casals, S. Retamozo, 2014, Annals of the rheumatic diseases.

Cryoglobulinaemic vasculitis at diagnosis predicts mortality in primary Sjögren syndrome: analysis of 515 patients.

B. Kostov, A. Sisó-Almirall, L. Quartuccio, 2016, Rheumatology.

Post-COVID-19 syndrome in patients with primary Sjögren's syndrome after acute SARS-CoV-2 infection.

V. Devauchelle-Pensec, A. Sisó-Almirall, B. Armağan, 2021, Clinical and experimental rheumatology.

Gender, body mass index and rheumatoid arthritis disease activity: results from the QUEST-RA Study.

Ahmad M. Nagm, M. Dougados, A. Woolf, 2010, Clinical and experimental rheumatology.